Browse studies

Find your next paid study

3,218 recruiting studies matching your filters

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided uri…

Bladder Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Cedars-Sinai Medical CenterNCT03193541

Quantitative Imaging Tools to Derive DW-MRI Oncological Biomarkers

Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be fe…

Head and Neck CancerThyroid Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT03483337

Phase 1

A Multicenter FIH Dose Escalation and Optimization Phase I/IIa Trial to Investigate Safety, Tolerability, PK, and Efficacy of the 5T4 ADC TUB-030 in Patients With Advanced Solid Tumors (5-STAR 1-01)

The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safety of TUB-030. The m…

Advanced Solid TumorsHNSCCSCLC+3 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Gilead SciencesNCT06657222

Bladder Bank (a Prospective Banking Study)

This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.

Bladder Carcinoma

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT06109857

Phase 1

An Open Label, Escalating Multiple Dose Study to Evaluate the Safety, Toxicity, and Pharmacokinetics of BTX A51 Alone and in Combination With Fulvestrant in Subjects With Advanced Solid Tumors and Estrogen Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer

This is a multicenter, open label, nonrandomized, sequential dose escalation/dose ranging, multiple dose study designed to evaluate the safety, toxicity, and P…

Advanced Solid TumorMetastatic Breast Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Edgewood Oncology Inc.NCT04872166

Observational

Consumer Evaluation of an Investigational Intermittent Catheter

This clinical study is designed to evaluate the initial safety and performance of an investigational intermittent urinary catheter in people who use intermitte…

Urinary RetentionNeurogenic Bladder

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Hollister IncorporatedNCT07714694

Phase 2

A Phase 2 Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy

This phase II randomized control trial assesses the effect of Urolithin A (Uro-A) supplementation compared to placebo in men with biopsy-confirmed prostate can…

Prostate Adenocarcinoma

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06022822

Phase 1

A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers

The purposes of this clinical study are 1. To see how the new drug (HMB-003) under study is tolerated in healthy volunteers, and if there are any important si…

Healthy Adult Participants

Estimated

~$500 – $11,250

Actual pay is set by the research site.

Hemab ApSNCT07798505

Characterization of Brain Morphology and Activity Using Functional and Anatomical MRI Contrast

The purpose of this investigation is to develop improved magnetic resonance imaging (MRI) techniques and hardware for studying brain function. MRI is a diagnos…

Healthy VolunteerMagnetic Resonance ImagingHealthy+3 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Neurological Disorders and Stroke (NINDS)NCT00004577

Phase 2

Phase II Study of the Combination of Blinatumomab and Ponatinib in Patients With Philadelphia Chromosome (Ph)-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)

This phase II trial studies how well blinatumomab, methotrexate, cytarabine, and ponatinib work in treating patients with Philadelphia chromosome (Ph)-positive…

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaBCR-ABL1 Fusion Protein Expression+5 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer Center

Phase 2

A Phase 2 Open Label Study of XL092 as First Line Therapy in Radioiodine Refractory Differentiated Thyroid Cancer

This phase II trial tests how well XL092 works for the treatment of patients with differentiated thyroid cancer that has not responded to previous treatment wi…

Locally Advanced Differentiated Thyroid Gland CarcinomaLocally Advanced Poorly Differentiated Thyroid Gland CarcinomaLocally Advanced Thyroid Gland Follicular Carcinoma+18 more

Estimated

Observational

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

This study is a double blind, placebo controlled, randomized trial of study subjects with PCOS and low vitamin D to 2 groups- placebo and vitamin D replacement…

Polycystic Ovarian Syndrome in Adolescent FemalesVitamin D Deficiency

Estimated

~$10 – $750

Actual pay is set by the research site.

Yale UniversityNCT04355572